Simultaneous allele-specific amplification: A strategy using modified primer-template mismatches for SNP detection - Application to prothrombin 20210A (factor II) and factor V Leiden (1691A) gene mutations

Molecular Diagnosis

Volumn 6, Issue 3, 2001, Pages 201-209

  Delrio Lafreniere, Susie A ^a   McGlennen, Ronald C ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Multiplex PCR; Primer design; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; NUCLEOTIDE; PRIMER DNA; PROTHROMBIN; RESTRICTION ENDONUCLEASE;

3' UNTRANSLATED REGION; ALLELE; ARTICLE; BASE MISPAIRING; DIAGNOSTIC VALUE; GENE AMPLIFICATION; GENE MUTATION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; THROMBOPHILIA;

EID: 0034810180     PISSN: 10848592     EISSN: None     Source Type: Journal    
DOI: 10.1054/modi.2001.26049     Document Type: Article

References (33)

1. Mutation in blood coagulation factor V associated with resistance to activated protein C
2. Factor V Leiden (G1691A), the prothrombin 3′-untranslated region variant (G20210A) and thermolabile methylenetetrahydrofolate reductase (C677T): A single genetic test genotypes all three loci - Determination of frequencies in the S Wales population of the UK
3. Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk for venous thromboembolism to carriers of factor V R506Q (factor V Leiden)
4. Factor V Cambridge: A new mutation (Arg306→Thr) associated with resistance to activated protein C
5. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C: Prediction of a cofactor to activated protein C
6. Thrombophilia as a multigenic disease
7. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
8. Geographic distribution of the 20210 G to A prothrombin variant
9. Prothrombin G20210A mutant genotype is a risk factor for cerebrovascular ischemic disease in young patients
10. Hemostatic effects of oral contraceptives in women who developed deep-vein thrombosis while using oral contraceptives
11. Prevalence of the prothrombin gene variant 20210 G→A among patients with myocardial infarction
12. Thrombotic risk during pregnancy: A population study
13. Preeclampsia and genetic risk factors for thrombosis: A case-control study
14. Simple and reliable factor V genotyping by PNA-mediated PCR clamping
15. An even easier method for one-step detection of both FV Leiden and FII G20210A transition
16. Multiplex PCR for one-step determination of the G20210A variation and the factor V Leiden mutation by denaturing gradient gel electrophoresis (DGGE)
17. Multiplex PCR-mediated site-directed mutagenesis for one-step determination of factor V Leiden and G20210A transition of the prothrombin gene
18. Simultaneous detection of FV Q506 and prothrombin 20210 A variation by allele-specific PCR
19. Rapid detection of the prothrombin 20210 A variation by allele specific PCR
20. Overlapping PCR for bidirectional PCR amplification of specific alleles: A rapid one-tube method for simultaneously differentiating homozygotes and heterozygotes
21. Multiplex ASA PCR for a simultaneous determination of factor V Leiden gene, G→A 20210 prothrombin gene and C→T 677 MTHFR gene mutations
22. Rapid simultaneous screening of factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood
23. Development of a simple multiplex polymerase chain reaction for the simultaneous detection of factor V Leiden and prothrombin 20210A mutations
24. Allele-specific PCR amplification of factor V Leiden to identify patients at risk for thromboembolism
25. Allele specific amplification by tetra-primer PCR
26. Rapid detection of the CYP2D6*3, CYP2D6*4, and CYP2D6*6 alleles by tetra-primer PCR and of the CYP2D6*5 allele by multiplex long PCR
27. Software to determine optimal oligonucleotide sequences based on hybridization simulation data
28. Selecting optimal oligonucleotide primers for multiplex PCR
29. Effects of primer-template mismatches on the polymerase chain reaction: Human immunodeficiency virus type 1 model studies
30. Complete cDNA and derived amino acid sequence of human factor V
31. Nucleotide sequence of the gene for human prothrombin
32. General concepts for PCR primer design
33. An alternative method for identifying the factor V gene Leiden mutation